Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 10, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record53120 flagged findings
Reported transactions (Form 4)80since Jun 11, 2025 · and 13 other holdings
Corporate events (8-K)21since Apr 6, 2021
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-12share offering or dilution eventrecentOpen filing ↗“…outstanding and held by such investors (the "Exchange Transactions"). The pre-funded warrants were issued without registration…”
+1 more passage from the same document
- “…time, the 2025 Sales Agreement), pursuant to which we may offer and sell, from time to time through TD Cowen, at our option, shares…”
- 2026-05-12capital return (buybacks/dividends)recentOpen filing ↗“…to (subject to certain qualifications and exceptions): create liens and encumbrances; incur additional indebtedness; merge,…”
+1 more passage from the same document
- “…112 Table of Contents Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. Recent Sales of Unregistered…”
- 2026-05-12Department of Justice inquiryrecentOpen filing ↗“…related to processing of personal data brought by classes of data subjects or consumer protection organizations authorized at law…”
+1 more passage from the same document
- “…Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 531)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 16, 26SCHEDULE 13D/A ↗Stake with intent to influence · BVF PARTNERS L P/IL · 9.8% · event on Oct 14, 26 · amendment new
- Oct 15, 268-K ↗Current report · A senior executive left or was appointed new
- Sep 2, 26Form 4 ↗Insider transaction
- Aug 13, 26Form 3 ↗Insider transaction
- Aug 13, 268-K ↗Current report · A senior executive left or was appointed
- Aug 10, 2610-Q ↗Quarterly report
- Aug 10, 268-K ↗Current report · Results
- Aug 6, 26SCHEDULE 13G/A ↗Passive stake · FMR LLC · 13.8% · event on Jun 30, 26 · amendment
- Jul 29, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 7.1% · event on Jun 30, 26 · amendment
- Jul 27, 26Form 4 ↗Insider transaction
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Jul 24, 26Form 144 ↗Notice of proposed sale
- Jul 23, 26Form 144 ↗Notice of proposed sale
Insider transaction · 9 Form 4 filingsshow all 9hide
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 26Form 4 ↗Insider transaction
- Jun 23, 268-K ↗Current report · Shareholder vote results
- May 26, 268-K ↗Current report · Communication to the market · Other events
531 filings on record, the oldest from Oct 16, 20.
Listing the 25 most recent filings of the 531 on record.
147
- Oct 15, 26A senior executive left or was appointed8-K 5.02 ↗
- Aug 13, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 1, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Apr 29, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jan 30, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jan 10, 25Sold unregistered shares+1 more in the same filing8-K 3.02 ↗
- Dec 2, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jul 2, 24Took on a new financial obligation+1 more in the same filing8-K 2.03 ↗
- Jan 5, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 18, 23A senior executive left or was appointed+2 more in the same filing8-K/A 5.02 ↗
4 material agreements entered2022 – 2023show all 4hide
- Oct 17, 23Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 10, 23Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Sep 5, 23Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jun 9, 22Entered a material agreement8-K 1.01 ↗
- Mar 14, 22A senior executive left or was appointed8-K 5.02 ↗
1 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- BVF PARTNERS L P/IL9.8%Oct 14, 26SCHEDULE 13D/A ↗11 co-filers on this document — the figure is the largest single stake, not their sum.
- Logos Global Management LP4.7%Mar 18, 25SCHEDULE 13D/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- FMR LLC13.8%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- JANUS HENDERSON GROUP PLC8.2%Mar 31, 26SCHEDULE 13G/A ↗2 earlier filings
- Bain Capital Life Sciences Opportunities IV, L.P.8.2%Mar 31, 26SCHEDULE 13G/A ↗3 earlier filings
- BlackRock, Inc.7.1%Jun 30, 26SCHEDULE 13G/A ↗
- Raymond Debbane5.1%Mar 16, 26SCHEDULE 13G ↗8 co-filers on this document — the figure is the largest single stake, not their sum.
show 2 more holdershide
- Deep Track Capital, LP5.0%Mar 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- Point72 Asset Management, L.P.2.3%Mar 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Jul 24, Harmon Cyrus filed notice of intent to sell up to $146K. That is about 0.01% of shares outstanding.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $146K on Jul 24, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+1 more recent notices · 1 with a later sale
- Jul 24, 26Sell$146KCyrus Harmon↗
- Jul 23, 26Sell$145KCyrus Harmon↗
- Mar 4, 26Sell$601KShawnte MitchellCHIEF LEGAL OFFICER↗
- Mar 4, 26Sell$6KShawnte MitchellCHIEF LEGAL OFFICER↗
- Mar 3, 26Sell$345KShawnte MitchellCHIEF LEGAL OFFICER↗
- Jan 20, 26Sell$269KCyrus Harmon↗
- Jan 15, 26Sell$2.9MShane William Charles KovacsCH. OPERATING & FINANCIAL OFF.↗
- Jan 14, 26Sell$429KDavid C. MylesCH. DISCOV. & NON-CLIN DEV OFF↗
- Jan 14, 26Sell$1.0MDavid C. MylesCH. DISCOV. & NON-CLIN DEV OFF↗
- Jan 14, 26Sell$102KCyrus Harmon↗
- Jan 13, 26Sell$1.4MDavid C. MylesCH. DISCOV. & NON-CLIN DEV OFF↗
- Jan 13, 26Sell$6KDavid C. MylesCH. DISCOV. & NON-CLIN DEV OFF↗
There are 13 more transactions in this stretch.
Stock compensation, tax and giftsshow the 15 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Mar 4, 26Compensation$109KShawnte MitchellCHIEF LEGAL OFFICER↗
- Mar 3, 26Compensation$66KShawnte MitchellCHIEF LEGAL OFFICER↗
- Feb 2, 26Compensationamount n/aSasha Lu AustinVP of Finance and Controller↗
- Jan 14, 26Compensation$244KDavid C. MylesCH. DISCOV. & NON-CLIN DEV OFF↗
- Jan 13, 26Compensation$244KDavid C. MylesCH. DISCOV. & NON-CLIN DEV OFF↗
- Dec 26, 25Giftamount n/aSean BohenPresident and CEO↗
- Dec 23, 25Compensation$351KNaseem ZojwallaChief Medical Officer↗
- Dec 22, 25Compensation$653KNaseem ZojwallaChief Medical Officer↗
- Dec 22, 25Compensation$50KNaseem ZojwallaChief Medical Officer↗
- Dec 19, 25Compensation$924KIAN T CLARK↗
- Dec 19, 25Compensation$78KIAN T CLARK↗
- Dec 19, 25Compensation$169KIAN T CLARK↗
- Dec 19, 25Compensation$49KIAN T CLARK↗
- Dec 19, 25Giftamount n/aDavid C. MylesCH. DISCOV. & NON-CLIN DEV OFF↗
- Dec 19, 25Compensation$610KNaseem ZojwallaChief Medical Officer↗
The full record holds 157 transactions and goes back to Feb 1, 23.
Its sector and its market
Olema Pharmaceuticals Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Olema Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Olema Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 531 documents on file, from Oct 16, 2020 to Oct 16, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.